Chunguang Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Signaling Pathway

Renal Cell Carcinoma

Endoplasmic Reticulum Stress

Top Venues

Journal for immunotherapy of cancer

Cancer research

International journal of general medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research 84 (16) (2024)
Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research 84 (16) (2024)
Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research (2024)
Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Zhenghao Liu, Chunguang Yang, Xing Zeng, Chunjin Ke, Jihua Tian, Zhihua Wang, Zhiquan Hu
Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study. Applied bionics and biomechanics 2022 (2022)
Zhiquan Hu, Jingjing Li, Chunguang Yang, Fen Chen, Zhihua Wang, Ping Lei, Guanxin Shen
Elevated SARS-Cov-2-Specific IgM Levels Indicate Clinically Unfavorable Outcomes in Patients with COVID-19: A Retrospective Cohort Study. International journal of general medicine 14 (2021)
Zhiquan Hu, Chunjin Ke, Yuanqing Shen, Xing Zeng, Chunguang Yang
Renal metastases from esophageal cancer and retroperitoneal lymphoma detected via chromosome duplications identified by fluorescence in situ hybridization in urine exfoliated cells: First 2 case reports. Medicine 100 (10) (2021)